From Name

From Email

To Name

To Email

Message

FDA approves heart failure treatment

from Medical Economics

FDA approves heart failure treatment Medical Economics The U.S. Food and Drug Administration (FDA) has approved a new treatment for a type of heart failure, according to a news release. Farxiga (dapagliflozin) oral tablets has been approved as a treatment for adults with heart failure with reduced ejection fraction. The drug reduces the risk of cardiovascular death and hospitalization for heart failure. READ MORE

more